Episode 70: Our Take, September 16, 2019
In today’s Our Take read-in, we review value-based payment models in oncology. If this is your field, this episode is one you don’t want to miss. To sign up for the weekly email brief, click here.
Other briefs include:
- The owners of Purdue Pharma, maker of OxyContin, tentatively agreed to pay $3 billion to settle opioid-related lawsuits.
- Cigna introduced a new program to make expensive gene therapies more accessible.
- 370 health care organizations signed a letter to Congress in support of bipartisan legislation to reform prior authorization requirements.
- Insurers will owe a record $1.3 billion in medical loss ratio rebates this year.
- Several executive moves.
In this episode
John Marchica is a veteran health care strategist and CEO of Darwin Research Group. He was the founder and CEO of FaxWatch, a leading business intelligence and medical education company and two-time member of the Inc. 500 list of America's fastest growing companies.
John is the author of The Accountable Organization and has advised senior management on strategy and organizational change for more than a decade. John earned his B.A. in economics from Knox College, an MBA and M.A. in public policy from The University of Chicago, and completed his Ph.D. coursework and doctoral exams in clinical epidemiology and health economics at The Dartmouth Institute for Health Policy and Clinical Practice. He is a faculty associate in the W.P. Carey School of Business and the College of Health Solutions at Arizona State University.
About Darwin Research Group
Darwin Research Group Inc. provides advanced market intelligence and in-depth customer insights to health care executives, with a strategic focus on health care delivery systems and the global shift toward value-based care. Darwin’s client list includes forward-thinking biopharmaceutical and medical device companies, as well as health care providers, private equity, and venture capital firms. The company was founded in 2010 as Darwin Advisory Partners, LLC and is headquartered in Scottsdale, Ariz. with a satellite office in Princeton, N.J.